96
Participants
Start Date
July 1, 2023
Primary Completion Date
December 1, 2025
Study Completion Date
June 1, 2026
Tofacitinib
For the tofacitinib the dose of 10 mg BD will be administered for 8 weeks (10 mg TDS for initial three days) and then reduced to 5 mg BD for the period of study
Cyclosporine
: Intravenous Cyclosporine 2 mg/kg continuous infusion for 5-7 days and then shifted to oral cyclosporine 4 mg/kg/day in two divided doses for 12 weeks.Those who respond with intravenous cyclosporine will be shifted to oral cyclosporine 4 mg/kg for 12 weeks while the thiopurine dose is adjusted to the patient's weight
All India Institute of Medical Sciences
OTHER
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER